Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.30
Delayed Data
As of 3:59pm ET
 -0.06 / -4.41%
Today’s Change
1.06
Today|||52-Week Range
2.12
-5.80%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Pluristem Therapeutics Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +169.23% increase from the last price of 1.30.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Pluristem Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$0.00
Reporting Date
Sep 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -800.00%
 
 
 
 
 
 
Growthannually 13.50%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.